PROCEPT BioRobotics (PRCT) Other Accumulated Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Other Accumulated Expenses data on file, last reported at $10.2 million in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $10.2 million, up 20.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 million (up 20.88% YoY), and the FY2025 annual result was $10.1 million, up 24.53% from the prior year.
• Other Accumulated Expenses advanced to $10.2 million in Q1 2026 per PRCT's latest filing, from $10.1 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $10.2 million in Q1 2026 and troughed at $4.0 million in Q1 2022.
• A 5-year average of $7.7 million and a median of $7.8 million in 2023 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses jumped 109.21% in 2022, then decreased 15.4% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $7.5 million in 2022, then declined by 15.4% to $6.3 million in 2023, then advanced by 28.03% to $8.1 million in 2024, then climbed by 24.53% to $10.1 million in 2025, then advanced by 1.75% to $10.2 million in 2026.
• Business Quant data shows PRCT's Other Accumulated Expenses at $10.2 million in Q1 2026, $10.1 million in Q4 2025, and $8.2 million in Q3 2025.